In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
- Results from this interim analysis showed ibrutinib plus rituximab prolonged progression-free survival (PFS) compared to a standard chemoimmunotherapy regimen of fludarabine, cyclophosphamide and rituximab (FCR) at nearly 3 years of follow-up (abstract #LBA-4)
-- New super-cores for BorgWarner's AirWerks® and Engineered for Racing (EFR™) lines of turbochargers make their Performance Racing Industry trade show debut
Study finds long-term safety and efficacy in subset of 33 hemophilia A patients who received treatment with Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) for five years was consistent with previous data analysis